dailyai.report

Insilico Medicine and China Medical System expanded their partnership to accelerate R&D for central nervous system diseases. The collaboration leverages generative AI to identify novel drug targets and optimize lead compounds. This deal streamlines the discovery pipeline for complex neurological conditions. Practitioners can expect faster iteration cycles in AI-driven biotech drug development.